How Founders Raise Growth Capital Without Diluting Their Equity Stake

Founders Can Raise Growth Equity Without Selling Their Equity Stake

For founders of publicly listed companies, equity is not simply a financial instrument — it represents years of work, risk, and conviction. When the business needs growth capital, the conventional route is to issue new shares, accept dilution, and welcome new investors onto the cap table. This works in some circumstances, but for many founders it is the last resort. There is an alternative approach that is widely used by experienced founders and family offices: accessing capital by pledging existing personal shareholdings as collateral, without issuing a single new share or bringing in a single new investor.

The Dilution Problem Every Founder Understands

Every equity capital raise dilutes the founder’s percentage ownership. A founder holding 55% of a listed company before a growth round may find themselves at 42% afterwards, depending on the size and valuation of the raise. Over successive rounds, this dilution compounds. Voting rights diminish, strategic influence narrows, and — if the dilution reaches a critical threshold — effective control of the business can shift away from the people who created it.

For founders of listed companies, the challenge is compounded by public visibility. A share placement or rights issue is disclosed to the market and can signal capital weakness at precisely the wrong moment, potentially depressing the share price during the raise and increasing the cost of capital further.

Accessing Capital at the Personal Level, Not the Company Level

The key distinction with pledging shares as collateral is that the transaction takes place at the individual level, not the corporate level. The founder uses their personally held shares in the listed company as security for a loan. No new shares are issued. No board approval is required. The company’s ownership structure, cap table, and the founder’s voting rights remain entirely unchanged.

The loan proceeds — typically 50–70% of the current market value of the pledged shares — are received by the founder as an individual. They can then inject that capital into the business as a shareholder loan, a working capital contribution, or an equity injection depending on the most appropriate structure for the business at that point in time. From the company’s perspective, it is receiving capital from its founder. From the founder’s perspective, they have unlocked that capital without permanently disposing of any part of their stake. A specialist in listed share collateral lending can structure this efficiently.

Common Growth Scenarios Funded This Way

Founders use this approach across a wide range of business growth situations. Geographic expansion — opening new offices, establishing operations in new markets, or funding an international licensing rollout — is one of the most common. The capital injection happens quickly, without a lengthy equity raise process or the boardroom negotiations that come with it.

Bolt-on acquisitions are another frequent use case. A founder who wants to acquire a smaller competitor or complementary business can fund that acquisition at the personal level, avoiding the need for shareholder approval or the involvement of institutional co-investors who may have different views on the strategic rationale.

Bridging between funding rounds is also common. Founders who are approaching a formal capital raise but need to keep the business moving in the interim — funding a key hire, completing a product development cycle, or meeting a contract commitment — use short-term share-backed facilities to avoid a premature or poorly-timed equity raise. The facility is repaid once the formal round closes.

Eligibility Considerations for Founders

The primary requirement is that the founder holds shares in a company listed on a recognised exchange. The lender will assess the liquidity of the shares — average daily trading volume, market capitalisation, and the founder’s percentage of the total shares in issue — to determine the maximum loan-to-value ratio and acceptable loan size.

Founders who hold a significant percentage of the company’s total issued shares should take independent legal advice before proceeding. Pledging shares as collateral may need to be disclosed under applicable market rules, shareholders’ agreements, or the company’s own share dealing policy. Most well-advised founders can navigate these requirements, but the legal groundwork matters and should be completed before any facility is committed to.

Structuring the Facility Correctly

The most important structural decision is the loan-to-value ratio. Borrowing the maximum available LTV leaves no buffer against share price volatility. If the share price falls and the loan balance approaches the margin call threshold, the lender may require additional collateral or partial repayment at a difficult moment. Founders should structure conservatively, building in a meaningful buffer between the initial LTV and the margin call level.

A non-recourse structure limits the founder’s liability to the pledged shares, protecting other personal assets if the share price declines materially during the loan term. Loan terms are typically 12 to 36 months, which gives sufficient runway to execute the growth strategy and generate a return before the facility falls due for repayment.

If you are a founder seeking growth capital and hold listed shares in your company, Platinum Global Bridging Finance can provide indicative terms quickly and structure a facility through our global panel of specialist lenders in pledging shares as collateral. Minimum loan sizes start from £1 million. Contact our team to discuss your position confidentially.

Related Articles

• How to Fund a Property Purchase Without Liquidating Your Share Portfolio
• How to Diversify a Concentrated Share Portfolio Without Triggering Capital Gains Tax
• Accessing Liquidity From Your Share Portfolio During a Divorce Settlement
• How Business Acquisitions Are Financed Using an Existing Share Portfolio